Jiandong L. Zhang - Publications

Integrated DIA proteomics of tissue and exudate reveals screening markers for early detection of ulcerative colitis and colorectal cancer.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: April 12, 2026

BTLA and PD-1 combined with radiotherapy for enhancing antitumor immune response in lung cancer via the regulation of memory B cells to promote T-cell infiltration.

Journal: Translational lung cancer research

Published: April 12, 2026

Macrophages in lung cancer: principal factors, regulatory mechanisms, and therapeutic opportunities: a narrative review.

Journal: Translational lung cancer research

Published: April 03, 2026

Patterns of progression and efficacy of immune checkpoint inhibitors in unresectable, recurrent, or metastatic cholangiocarcinoma: A real-world study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 01, 2026

Physical activity and cancer survival: the role of peripheral blood immune and inflammatory markers in reducing mortality-a retrospective cohort study based on NHANES 1999-2018.

Journal: Translational cancer research

Published: March 03, 2026

Development and validation of nomograms integrating electrolyte, nutritional, and inflammatory indicators to predict survival in advanced esophageal cancer undergoing immunotherapy or radioimmunotherapy.

Journal: Journal of thoracic disease

Published: February 08, 2026

Contribution of immune cells and cytokines to radiation-induced injury: the key roles and potential targets.

Journal: Frontiers in immunology

Published: January 12, 2026

Integrated management of immunotherapy and radiotherapy for patients with metastatic non-small cell lung cancer: a narrative review of current landscape and future directions.

Journal: Translational lung cancer research

Published: January 05, 2026

Biomaterials Based on Bacteria for Cancer Clinical Therapy.

Journal: Biomaterials research

Published: December 15, 2025

Induction immunochemotherapy followed by concurrent chemoradiotherapy improves survival in unresectable esophageal cancer: a systematic review, meta-analysis, and network meta-analysis.

Journal: Frontiers in immunology

Published: December 14, 2025

Crosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor Therapy.

Journal: Cancer medicine

Published: November 05, 2025

Camrelizumab Combined with Gemcitabine and Albumin-Bound Paclitaxel in Pancreatic Cancer Patients with Liver Metastases: A Prospective, Pilot Trial.

Journal: Drug design, development and therapy

Published: October 09, 2025